Sunday, March 2, 2025

Target’s DEI problem, Apple woos Trump, and cheap weight loss drugs: Business news roundup

Must read

Photo: Subaru, NurPhoto (Getty Images), Al Drago/Bloomberg (Getty Images), Galit Rodan/Bloomberg (Getty Images), Image: Bloomberg / Contributor (Getty Images), Shelby Knowles/Bloomberg (Getty Images), Gary Hershorn (Getty Images), Hims & Hers (Getty Images), Justin Sullivan / Staff (Getty Images)
Photo: Subaru
Photo: Subaru

If you’re looking for a new car in 2025, Consumer Reports (CR) has you covered.

The nonprofit consumer organization just released its list of the 10 best new cars to buy in 2025, broken down by category.

To make the list, vehicles had to score highly on their road and safety tests. CR also factored in reliability and owner satisfaction and said cars had to include low-speed automatic emergency braking with pedestrian detection and highway-speed automatic emergency braking technology.

Read More

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. - Image: Bloomberg / Contributor (Getty Images)
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. – Image: Bloomberg / Contributor (Getty Images)

Eli Lilly (LLY) is making more doses of its blockbuster weight-loss drug Zepbound available in vials and at lower prices.

The pharma giant announced on Tuesday that it is now expanding its single-dose vial offerings of Zepbound to include higher doses.

Last August, Eli Lilly began selling the lowest doses of Zepbound — 2.5 mg and 5 mg — in vials rather than the standard auto-injector pen, cutting the price by about half. Now, it’s adding two higher doses to the mix and further reducing the price of the lower ones.

Read More

A Target store in New York. - Image: Shelby Knowles/Bloomberg (Getty Images)
A Target store in New York. – Image: Shelby Knowles/Bloomberg (Getty Images)

Target (TGT) announced it was scaling back its Diversity, Equity, and Inclusion (DEI) efforts one month ago. Now, the retail giant is seeing a rapid decline in store visits.

Read More

People walk through the parking lot at a Costco on Feb. 1, 2025, in Bayonne, New Jersey. - Image: Gary Hershorn (Getty Images)
People walk through the parking lot at a Costco on Feb. 1, 2025, in Bayonne, New Jersey. – Image: Gary Hershorn (Getty Images)

Costco (COST) is best known for its no-frills, bulk-buying experience, but the warehouse giant also moves a surprising amount of luxury goods.

From Rolex watches to gold bars, high-end items have become an integral part of the business, and according to Hamilton “Tony” James, chairman of Costco, wealthier shoppers are hooked.

Read More

Photo: Getty (Getty Images)
Photo: Getty (Getty Images)

Companies from Disney (DIS) to Walmart (WMT) are ditching DEI as the Trump administration has put a chill on such efforts by eliminating it from federal programs.

Read More

Hims & Hers will start selling generic liraglutide later this year. - Image: Hims & Hers (Getty Images)
Hims & Hers will start selling generic liraglutide later this year. – Image: Hims & Hers (Getty Images)

Hims & Hers (HIMS) made a killing last year selling an off-brand version of Ozempic, but with the drug’s shortage now over, the company will soon have to halt sales of its cheaper alternative. That said, the millennial-focused telehealth company still has a few options on the table.

Read More

Apple CEO Tim Cook and President Donald Trump chat at an American Workforce Policy Advisory board meeting in March 2019, during the president’s first term in office. - Photo: Al Drago/Bloomberg (Getty Images)
Apple CEO Tim Cook and President Donald Trump chat at an American Workforce Policy Advisory board meeting in March 2019, during the president’s first term in office. – Photo: Al Drago/Bloomberg (Getty Images)

Apple’s (AAPL) new $500 billion investment plan is winning over President Donald Trump — and proving that CEO Tim Cook knows how to play ball.

Latest article